Please provide your email address to receive an email when new articles are posted on . Elevated soluble suppressor of tumorigenicity, or ST2, was associated with unfavorable pulmonary outcomes and ...
Critical Diagnostics announced today, , an American Heart Association Journal, released online the first study evaluating the power of ST2 to predict development of heart failure and other adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback